Strengthening National Health Laboratory Services in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 158703CONT17

Opportunity Information: Apply for CDC RFA GH15 158703CONT17

The grant opportunity titled "Strengthening National Health Laboratory Services in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a U.S. government funding announcement focused on improving and supporting Tanzania's national health laboratory systems as part of the broader PEPFAR initiative. PEPFAR is the United States' global program aimed primarily at addressing HIV/AIDS, and laboratory services are a core backbone of HIV prevention, diagnosis, treatment monitoring, and broader public health response. This opportunity is structured to continue work already underway rather than start a brand-new project from scratch, which is reflected in its classification as a continuation award.

This funding announcement is issued by the U.S. Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC), specifically under CDC's global health programming (Agency listed as "Centers for Disease Control - CGH"). The funding mechanism is a cooperative agreement, meaning the CDC is expected to have substantial involvement in the funded work. In practice, cooperative agreements typically involve close technical collaboration, joint planning, and ongoing oversight between the recipient and CDC, rather than a hands-off relationship where a grantee operates independently.

The opportunity is categorized under the health activity area and is associated with CFDA number 93.067, which corresponds to CDC-related global health assistance programming. Only one award was expected to be made under this announcement, signaling that it was likely intended for a specific continuing partner or a narrow set of eligible organizations capable of sustaining national-level laboratory strengthening work. The eligibility field indicates "Others (see text field entitled Additional Information on Eligibility for clarification)," which implies that eligibility was not open broadly to every applicant type and would have depended on the detailed eligibility language in the full notice (for example, it could have been limited to an incumbent implementing partner, organizations with particular in-country presence, or entities meeting specialized capacity requirements).

In terms of timing, the opportunity was created on October 12, 2016, and the original application closing date was December 12, 2016. Those dates reflect the administrative window for the continuation action at that time. The listing shows an award ceiling of 0, which commonly indicates that a specific maximum funding cap was not published in the summary record or that the funding level was determined through continuation budgeting rather than a competitive ceiling amount stated upfront. Even when a ceiling is not shown, continuation cooperative agreements typically operate under a defined approved budget that aligns with PEPFAR planning cycles and CDC determinations.

While the brief record does not provide programmatic details like objectives, work plan components, or required outcomes, the title clearly indicates a focus on national health laboratory services in Tanzania in support of PEPFAR goals. In a laboratory-strengthening context tied to HIV programs, this kind of award often supports activities such as improving laboratory quality management systems, expanding and sustaining diagnostic and monitoring capacity (including tests used in HIV care), strengthening specimen referral networks, improving biosafety and biosecurity practices, developing workforce competency through training and mentorship, upgrading laboratory information systems and data use, and supporting national reference laboratory functions and coordination across tiers of the health system. Because it is described as "strengthening national" services, the scope usually goes beyond individual facilities and emphasizes system-level improvements, standardization, and sustainability within national structures.

Overall, this grant opportunity represents a CDC-administered PEPFAR continuation cooperative agreement intended to maintain and advance Tanzania's laboratory system capacity at a national scale, with a single expected recipient, a health-focused program category, and an implementation approach that involves active CDC partnership throughout the award period.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthening National Health Laboratory Services in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 12, 2016.
• Applicants must submit their applications by Dec 12, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 158703CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: